CLINICAL_TRIALS
trial_result
· 2019-06-26
Clinical Trial Update: SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS [Phase 2]
Summary
Phase 2 clinical trial comparing terbinafine 1% topical solution to butenafine 1% topical solution for treating tinea pedis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Laboratories | Conditions: Tinea Pedis | Phase 2 | Status: UNKNOWN